SNRI ' Shows Promise ' for Comorbid ADHD, PTSD SNRI ' Shows Promise ' for Comorbid ADHD, PTSD

The SNRI atomoxetine may help improve outcomes for patients with both attention-deficit/hyperactivity disorder and posttraumatic stress disorder, new research suggests.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Psychiatry News Source Type: news